Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston ...

The clinical-stage biotech is developing gene-editing CRISPR technology. Editas has reported encouraging testing results in ...

One way would be to ensure there is a consistent and predictable yield year by year. For two years in a row, beginning in the ...

The well-studied NF-κB signaling system is a key mediator of the inflammatory response. Large-scale sequencing studies in ...

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations ...

Researchers have identified several uncharacterized chromatin factors and a gene that are involved in DNA repair.

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Eli Lilly is acquiring Verve Therapeutics to strengthen its cardiovascular pipeline with a gene-editing drug targeting PCSK9-linked conditions.